These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33589432)

  • 1. G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.
    Kelly GM; Al-Ejeh F; McCuaig R; Casciello F; Ahmad Kamal N; Ferguson B; Pritchard AL; Ali S; Silva IP; Wilmott JS; Long GV; Scolyer RA; Rao S; Hayward NK; Gannon F; Lee JS
    Clin Cancer Res; 2021 May; 27(9):2624-2635. PubMed ID: 33589432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G9a inhibition induced PKM2 regulates autophagic responses.
    Ahmad F; Dixit D; Joshi SD; Sen E
    Int J Biochem Cell Biol; 2016 Sep; 78():87-95. PubMed ID: 27417236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
    Colyn L; Bárcena-Varela M; Álvarez-Sola G; Latasa MU; Uriarte I; Santamaría E; Herranz JM; Santos-Laso A; Arechederra M; Ruiz de Gauna M; Aspichueta P; Canale M; Casadei-Gardini A; Francesconi M; Carotti S; Morini S; Nelson LJ; Iraburu MJ; Chen C; Sangro B; Marin JJG; Martinez-Chantar ML; Banales JM; Arnes-Benito R; Huch M; Patino JM; Dar AA; Nosrati M; Oyarzábal J; Prósper F; Urman J; Cubero FJ; Trautwein C; Berasain C; Fernandez-Barrena MG; Avila MA
    Hepatology; 2021 Jun; 73(6):2380-2396. PubMed ID: 33222246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of autophagy by the methyltransferase G9a.
    Artal-Martinez de Narvajas A; Gomez TS; Zhang JS; Mann AO; Taoda Y; Gorman JA; Herreros-Villanueva M; Gress TM; Ellenrieder V; Bujanda L; Kim DH; Kozikowski AP; Koenig A; Billadeau DD
    Mol Cell Biol; 2013 Oct; 33(20):3983-93. PubMed ID: 23918802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
    Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
    Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma.
    Ren A; Qiu Y; Cui H; Fu G
    Biochem Biophys Res Commun; 2015 Mar; 459(1):10-7. PubMed ID: 25634693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma.
    Li KC; Hua KT; Lin YS; Su CY; Ko JY; Hsiao M; Kuo ML; Tan CT
    Mol Cancer; 2014 Jul; 13():172. PubMed ID: 25027955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
    Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
    Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Zhou M; Zhang X; Liu C; Nie D; Li S; Lai P; Jin Y
    Oncogene; 2021 May; 40(20):3564-3577. PubMed ID: 33931742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
    Cao YP; Sun JY; Li MQ; Dong Y; Zhang YH; Yan J; Huang RM; Yan X
    Acta Pharmacol Sin; 2019 Aug; 40(8):1076-1084. PubMed ID: 30765842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
    Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
    Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
    Irifuku T; Doi S; Sasaki K; Doi T; Nakashima A; Ueno T; Yamada K; Arihiro K; Kohno N; Masaki T
    Kidney Int; 2016 Jan; 89(1):147-57. PubMed ID: 26444031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
    Ali A; Shafarin J; Unnikannan H; Al-Jabi N; Jabal RA; Bajbouj K; Muhammad JS; Hamad M
    Int J Biol Sci; 2021; 17(15):4474-4492. PubMed ID: 34803511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation.
    Ding J; Li T; Wang X; Zhao E; Choi JH; Yang L; Zha Y; Dong Z; Huang S; Asara JM; Cui H; Ding HF
    Cell Metab; 2013 Dec; 18(6):896-907. PubMed ID: 24315373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
    Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
    Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
    Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.
    Liu CW; Hua KT; Li KC; Kao HF; Hong RL; Ko JY; Hsiao M; Kuo ML; Tan CT
    Mol Cancer Ther; 2017 Jul; 16(7):1421-1434. PubMed ID: 28265008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Druggable epigenetic suppression of interferon-induced chemokine expression linked to
    Seier JA; Reinhardt J; Saraf K; Ng SS; Layer JP; Corvino D; Althoff K; Giordano FA; Schramm A; Fischer M; Hölzel M
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.